Movement Alert|Moderna Rises 5.07% in Regular Trading, Trading at $47.975

Market Focus05-20 22:28

On May 20, Moderna rose 5.07% in regular trading, trading at $47.975 USD/share, with trading volume of approximately $51.74 million.

Within the Biotechnology sector where Moderna belongs, among individual stocks, Immunovant up 31.1%, Roivant Sciences up 14.91%, Regeneron Pharmaceuticals up 2.09%, Amgen down 0.29%, AbbVie down 0.4%.

Moderna is a leader in the field of messenger RNA (mRNA) medicine. Its mRNA platform has enabled the development of therapeutics and vaccines across infectious diseases, immuno-oncology, rare diseases, and autoimmune diseases.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment